CCI study supports renal denervation for milder hypertension

05/24/2013 | Cardiology Today's Intervention magazine

Data from a pilot study published in Catheterization and Cardiovascular Interventions suggest renal denervation is safe and effective for treatment of mild resistant hypertension, findings that "[expand] the potential boundaries for renal denervation," according to an accompanying editorial by SCAI fellow Dr. Deepak Bhatt. No adverse events were documented in the study of 20 patients, while four were able to scale back antihypertensive therapies by the three-month follow-up.

View Full Article in:

Cardiology Today's Intervention magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ